Pan Wang
Zhengzhou, 450046, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy.
Journal: European journal of medicinal chemistry
Published: September 27, 2025
Targeting amyloid-β in Alzheimer's disease: A critical analysis of clinical trials and their implications for drug development.
Journal: Iranian journal of basic medical sciences
Published: September 23, 2025
Structural modification of atractylenolides: synthesis and evaluation of derivatives with potent anti-Aβ aggregation and neuroprotective activities against Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry letters
Published: September 04, 2025
Mechanism of Atractylodis Rhizoma in improving cognitive dysfunction in Alzheimer's disease by regulating the cAMP/CREB/BDNF pathway.
Journal: International immunopharmacology
Published: August 28, 2025
Photocatalyzed Oxycarboranylation and Hydrocarboranylation of Unsaturated C-C Bonds with 1-Iodo-2-methyl-o-carboranes as the Synthon.
Journal: Organic letters
Published: August 13, 2025
Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation.
Journal: Journal of ethnopharmacology
Published: July 10, 2025
Discovery of Atractylenolide Derivatives as Novel LSD1 Inhibitors for the Treatment of Alzheimer's Disease.
Journal: Journal of agricultural and food chemistry
Published: June 05, 2025
Cycloastragenol Regulates Mitochondrial Homeostasis-Mediated Renal Tubular Injury to Ameliorate Diabetic Kidney Disease by Directly Targeting ERK to Modulate TFEB.
Journal: Phytotherapy research : PTR
Published: April 09, 2025
Integrated multi-omics analysis and experimental validation reveals the mechanism of tenuifoliside A activity in Alzheimer's disease.
Journal: Journal of ethnopharmacology
Published: April 02, 2025
Cornuside as a promising therapeutic agent for diabetic kidney disease: Targeting regulation of Ca2+ disorder-mediated renal tubular epithelial cells apoptosis.
Journal: International immunopharmacology
Published: January 05, 2025
Metabolomic and microbial insights: Kai-Xin-San's impact on Alzheimer's disease pathology.
Journal: iScience
Published: October 29, 2024
Atractylenolide III Mitigates Alzheimer's Disease by Enhancing Autophagy via the YY1-TFEB Pathway.
Journal: Phytotherapy research : PTR
Published: October 25, 2024
Last Updated: 09/26/2026